Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Blood Cancer Journal|November 7, 2018
Deferred autologous stem cell transplantation in systemic AL amyloidosisRicha Manwani, Ute Hegenbart, Shameem Mahmood, et al.Frontiers in Immunology|August 7, 2018
CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront ResistanceAnja Seckinger, Jens Hillengass, Martina Emde, et al.Cell Reports Methods|December 1, 2022
A high-throughput electron tomography workflow reveals over-elongated centrioles in relapsed/refractory multiple myelomaTobias Dittrich, Sebastian Köhrer, Martin Schorb, et al.Cytometry. Part B, Clinical Cytometry|March 27, 2018
Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myelomaKatharina Kriegsmann, Tobias Dittrich, Brigitte Neuber, et al.International Journal of Cancer|May 9, 2014
Breast carcinoma cells modulate the chemoattractive activity of human bone marrow-derived mesenchymal stromal cells by interfering with CXCL12Manja Wobus, Catrin List, Tobias Dittrich, et al.British Journal of Haematology|August 3, 2021
Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow-upMarco Basset, Christoph R Kimmich, Nicholas Schreck, et al.Computers in Biology and Medicine|April 3, 2026
Constructing a corpus of hematologic pathology notes for the fine-tuning of BERT models for named entity recognitionDesiree Jaschke, Celine-Fabienne Bergmann, Max Blumenstock, et al.Digital Health|February 23, 2026
Single source - triple flow: Structured electronic data capture for pancreatic surgery patientsMax Blumenstock, Fleur Fritz-Kebede, Niels Siegel, et al.American Journal of Hematology|July 1, 2020
Localized immunoglobulin light chain amyloidosis: Novel insights including prognostic factors for local progressionMarco Basset, Kamal Hummedah, Christoph Kimmich, et al.Haematologica|June 19, 2025
Characterization, outcome and identification of prognostic factors for patients with systemic immunoglobulin light-chain amyloidosis requiring dialysis prior to initial anti-clonal therapyLilli S Sester, Paolo Milani, Fenia Theodorakakou, et al.Pageof 3